Relay Therapeutics (RLAY) launched an underwritten public offering of $175 million of common stock.
Underwriters are set to receive a 30-day option to buy up to an additional 15% of the offering, the company said Tuesday in a statement.
Relay shares fell 4.1% in after-hours trading.